CDTX vs INTC · rev $1.3M vs rev $52.85B
Cidara Therapeutics Inc (CDTX) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported INTC revenue for 2025-12-27 was $52.85B. Net income was -$267.0M. Revenue was down 0.5% from 2024-12-28 to 2025-12-27. INTC currently screens at market cap $498.43B.
CDTX currently screens at market cap $6.96B. INTC currently screens at market cap $498.43B.
Not investment advice. Open the CDTX and INTC stock pages for the full models.
Not investment advice.